Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-12

AUTHORS

S. Bonvalot, H. Eldweny, C. Le Péchoux, D. Vanel, P. Terrier, A. Cavalcanti, C. Robert, N. Lassau, A. Le Cesne

ABSTRACT

BACKGROUND: The role for surgery in patients with "unresectable" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery. METHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib. RESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery. CONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients. More... »

PAGES

1596-1603

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3

DOI

http://dx.doi.org/10.1245/s10434-006-9047-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035624784

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16957966


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Stromal Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Necrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peritoneal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Preoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonvalot", 
        "givenName": "S.", 
        "id": "sg:person.01114352422.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114352422.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eldweny", 
        "givenName": "H.", 
        "id": "sg:person.01261756132.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261756132.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiotherapy, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "P\u00e9choux", 
        "givenName": "C. Le", 
        "id": "sg:person.01104541475.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104541475.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vanel", 
        "givenName": "D.", 
        "id": "sg:person.01036545346.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036545346.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Pathology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Terrier", 
        "givenName": "P.", 
        "id": "sg:person.01157213662.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157213662.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavalcanti", 
        "givenName": "A.", 
        "id": "sg:person.01316771114.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316771114.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Medical Oncology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robert", 
        "givenName": "C.", 
        "id": "sg:person.011436723362.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011436723362.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lassau", 
        "givenName": "N.", 
        "id": "sg:person.0745512151.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745512151.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Medical Oncology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cesne", 
        "givenName": "A. Le", 
        "id": "sg:person.0647047157.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647047157.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00000658-200001000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002575802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-200001000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002575802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cad.0000132236.38297.a7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005289424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cad.0000132236.38297.a7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005289424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)80608-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007366528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)80608-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007366528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)17098-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012604875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013401985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00261-003-0021-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021193217", 
          "https://doi.org/10.1007/s00261-003-0021-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa020461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022255922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0093-7754(01)90099-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024450281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026114831", 
          "https://doi.org/10.1245/aso.2004.09.011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026114831", 
          "https://doi.org/10.1245/aso.2004.09.011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200104053441404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026751453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004280000338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027401391", 
          "https://doi.org/10.1007/s004280000338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000074470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033746965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2005.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034339089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2004.06.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035818796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00836-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039677991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00836-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039677991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/hupa.2002.123545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039925107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.11-1-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045697619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjsurg.2003.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047135793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800051093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049559447", 
          "https://doi.org/10.1007/s002800051093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0039-6060(03)00314-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053453048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/sonc.2001.29181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057078474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-12", 
    "datePublishedReg": "2006-12-01", 
    "description": "BACKGROUND: The role for surgery in patients with \"unresectable\" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery.\nMETHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib.\nRESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery.\nCONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-006-9047-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era", 
    "pagination": "1596-1603", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a9b447ab23dd04c832a8c7ee24cc14c6e538ebd29197dc8e22feb816b0e328d5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16957966"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-006-9047-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035624784"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-006-9047-3", 
      "https://app.dimensions.ai/details/publication/pub.1035624784"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000500.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1245/s10434-006-9047-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      21 PREDICATES      74 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-006-9047-3 schema:about N045fb7bca1d247e3925c40246bd470ec
2 N12dac0461415494f86f05f9b88a1a869
3 N281ee02f47264877979d44c493ae5ebe
4 N3a2d951724a94e27955588277dff5ddd
5 N4214a564a51f49d28d01371fe7c2ff81
6 N4d235d3a043e40a084360866ba0cd908
7 N5e045204b1ea4c5289a2176cbfe11a7d
8 N633260b5ee9844f3bf8f6e10d5fd49a3
9 N6e9bcd4977e64236a6f1376e114e7584
10 N74ca1c69fbcc4521997c3f8a02ace949
11 N74d6cee61c0b432dad8c27b687f3c3af
12 N848e0518d9d54357a1ce524854360864
13 N8bd0b87ca27d4c30bc8147500b7d2c75
14 N8dff177e4ee9432291443d3d32a460d8
15 N944c6b53f3f14e958af84de50aa2f300
16 N9fd99b4c38ff46f8b8842b8e8d47f853
17 Nad54e15e14b443c0838421f26a6de58a
18 Nb4200edad057425abddb479efe4a9ea8
19 Nda740a3e833b4233b8d925f0c0adff69
20 Ne405e67ca8ea4d73b50d22c698f3c83c
21 Ne96e95e4ce6e4af4b5da6f1275f0c245
22 Nf317feb523d94796bc60b545d8e49344
23 Nf5f4c806e2fb4c0ea4c2a52c49cd3892
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author N961950647d4441f0897a6abdbd3441ae
27 schema:citation sg:pub.10.1007/s00261-003-0021-2
28 sg:pub.10.1007/s002800051093
29 sg:pub.10.1007/s004280000338
30 sg:pub.10.1245/aso.2004.09.011
31 https://doi.org/10.1016/j.amjsurg.2003.08.023
32 https://doi.org/10.1016/j.ejrad.2005.01.012
33 https://doi.org/10.1016/j.ejso.2004.06.016
34 https://doi.org/10.1016/s0039-6060(03)00314-3
35 https://doi.org/10.1016/s0093-7754(01)90099-5
36 https://doi.org/10.1016/s0140-6736(04)17098-0
37 https://doi.org/10.1016/s0959-8049(02)00836-5
38 https://doi.org/10.1016/s0959-8049(02)80608-6
39 https://doi.org/10.1053/hupa.2002.123545
40 https://doi.org/10.1053/sonc.2001.29181
41 https://doi.org/10.1056/nejm200104053441404
42 https://doi.org/10.1056/nejmoa020461
43 https://doi.org/10.1080/01621459.1958.10501452
44 https://doi.org/10.1093/annonc/mdi127
45 https://doi.org/10.1097/00000658-200001000-00008
46 https://doi.org/10.1097/01.cad.0000132236.38297.a7
47 https://doi.org/10.1159/000074470
48 https://doi.org/10.1634/theoncologist.11-1-9
49 schema:datePublished 2006-12
50 schema:datePublishedReg 2006-12-01
51 schema:description BACKGROUND: The role for surgery in patients with "unresectable" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery. METHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib. RESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery. CONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf N126cec44eb7e4867aabe73818aac35bb
56 N7be1b201e0e642c7a0bfcb5104121ffd
57 sg:journal.1105545
58 schema:name Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era
59 schema:pagination 1596-1603
60 schema:productId N649c214c0ca84d3bb1093f77af0457d5
61 N94461f61394f41f184a8c23f144a6e74
62 Na439d4a5251047b2b5a1d931bb8d8db2
63 Nb676a590b38548b298657b50ad124545
64 Nbc19546bbb2d44bbbbf46bd6e53bd10c
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035624784
66 https://doi.org/10.1245/s10434-006-9047-3
67 schema:sdDatePublished 2019-04-10T19:06
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N6b50cd3b01994b71b3353f408c89feba
70 schema:url http://link.springer.com/10.1245/s10434-006-9047-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N045fb7bca1d247e3925c40246bd470ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Male
76 rdf:type schema:DefinedTerm
77 N0c2b44ae5b2f49eb8cea6c5b124ae60e rdf:first sg:person.01261756132.64
78 rdf:rest Nbcf3c28b6b7d4005aeedc6b42bd6a0eb
79 N126cec44eb7e4867aabe73818aac35bb schema:issueNumber 12
80 rdf:type schema:PublicationIssue
81 N12dac0461415494f86f05f9b88a1a869 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Gastrointestinal Stromal Tumors
83 rdf:type schema:DefinedTerm
84 N26604b925543460b91211cf5a8148e33 rdf:first sg:person.0745512151.35
85 rdf:rest N66da880362db471281df4950667211ec
86 N281ee02f47264877979d44c493ae5ebe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Aged
88 rdf:type schema:DefinedTerm
89 N3a2d951724a94e27955588277dff5ddd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Survival Rate
91 rdf:type schema:DefinedTerm
92 N3dcba48810d5470ca6c1e9cd20604090 rdf:first sg:person.01316771114.04
93 rdf:rest N3ddb1fd68bf040679b814265ad336764
94 N3ddb1fd68bf040679b814265ad336764 rdf:first sg:person.011436723362.08
95 rdf:rest N26604b925543460b91211cf5a8148e33
96 N4214a564a51f49d28d01371fe7c2ff81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Imatinib Mesylate
98 rdf:type schema:DefinedTerm
99 N4d235d3a043e40a084360866ba0cd908 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adolescent
101 rdf:type schema:DefinedTerm
102 N5e045204b1ea4c5289a2176cbfe11a7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Medical Records
104 rdf:type schema:DefinedTerm
105 N633260b5ee9844f3bf8f6e10d5fd49a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Benzamides
107 rdf:type schema:DefinedTerm
108 N649c214c0ca84d3bb1093f77af0457d5 schema:name doi
109 schema:value 10.1245/s10434-006-9047-3
110 rdf:type schema:PropertyValue
111 N66da880362db471281df4950667211ec rdf:first sg:person.0647047157.16
112 rdf:rest rdf:nil
113 N6b50cd3b01994b71b3353f408c89feba schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N6e9bcd4977e64236a6f1376e114e7584 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Pyrimidines
117 rdf:type schema:DefinedTerm
118 N7068a05b577849f8a9e1c836e7af7657 rdf:first sg:person.01157213662.74
119 rdf:rest N3dcba48810d5470ca6c1e9cd20604090
120 N74ca1c69fbcc4521997c3f8a02ace949 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Female
122 rdf:type schema:DefinedTerm
123 N74d6cee61c0b432dad8c27b687f3c3af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Retrospective Studies
125 rdf:type schema:DefinedTerm
126 N7a256d69115b4cf29e62653693f50030 rdf:first sg:person.01036545346.36
127 rdf:rest N7068a05b577849f8a9e1c836e7af7657
128 N7be1b201e0e642c7a0bfcb5104121ffd schema:volumeNumber 13
129 rdf:type schema:PublicationVolume
130 N848e0518d9d54357a1ce524854360864 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Protein-Tyrosine Kinases
132 rdf:type schema:DefinedTerm
133 N8bd0b87ca27d4c30bc8147500b7d2c75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Necrosis
135 rdf:type schema:DefinedTerm
136 N8dff177e4ee9432291443d3d32a460d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Preoperative Care
138 rdf:type schema:DefinedTerm
139 N94461f61394f41f184a8c23f144a6e74 schema:name readcube_id
140 schema:value a9b447ab23dd04c832a8c7ee24cc14c6e538ebd29197dc8e22feb816b0e328d5
141 rdf:type schema:PropertyValue
142 N944c6b53f3f14e958af84de50aa2f300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Liver Neoplasms
144 rdf:type schema:DefinedTerm
145 N961950647d4441f0897a6abdbd3441ae rdf:first sg:person.01114352422.70
146 rdf:rest N0c2b44ae5b2f49eb8cea6c5b124ae60e
147 N9fd99b4c38ff46f8b8842b8e8d47f853 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Peritoneal Neoplasms
149 rdf:type schema:DefinedTerm
150 Na439d4a5251047b2b5a1d931bb8d8db2 schema:name pubmed_id
151 schema:value 16957966
152 rdf:type schema:PropertyValue
153 Nad54e15e14b443c0838421f26a6de58a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 Nb4200edad057425abddb479efe4a9ea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 Nb676a590b38548b298657b50ad124545 schema:name dimensions_id
160 schema:value pub.1035624784
161 rdf:type schema:PropertyValue
162 Nbc19546bbb2d44bbbbf46bd6e53bd10c schema:name nlm_unique_id
163 schema:value 9420840
164 rdf:type schema:PropertyValue
165 Nbcf3c28b6b7d4005aeedc6b42bd6a0eb rdf:first sg:person.01104541475.09
166 rdf:rest N7a256d69115b4cf29e62653693f50030
167 Nda740a3e833b4233b8d925f0c0adff69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adult
169 rdf:type schema:DefinedTerm
170 Ne405e67ca8ea4d73b50d22c698f3c83c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Antineoplastic Agents
172 rdf:type schema:DefinedTerm
173 Ne96e95e4ce6e4af4b5da6f1275f0c245 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Piperazines
175 rdf:type schema:DefinedTerm
176 Nf317feb523d94796bc60b545d8e49344 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Disease-Free Survival
178 rdf:type schema:DefinedTerm
179 Nf5f4c806e2fb4c0ea4c2a52c49cd3892 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Feasibility Studies
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1105545 schema:issn 1068-9265
189 1534-4681
190 schema:name Annals of Surgical Oncology
191 rdf:type schema:Periodical
192 sg:person.01036545346.36 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
193 schema:familyName Vanel
194 schema:givenName D.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036545346.36
196 rdf:type schema:Person
197 sg:person.01104541475.09 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
198 schema:familyName Péchoux
199 schema:givenName C. Le
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104541475.09
201 rdf:type schema:Person
202 sg:person.01114352422.70 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
203 schema:familyName Bonvalot
204 schema:givenName S.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114352422.70
206 rdf:type schema:Person
207 sg:person.011436723362.08 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
208 schema:familyName Robert
209 schema:givenName C.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011436723362.08
211 rdf:type schema:Person
212 sg:person.01157213662.74 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
213 schema:familyName Terrier
214 schema:givenName P.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157213662.74
216 rdf:type schema:Person
217 sg:person.01261756132.64 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
218 schema:familyName Eldweny
219 schema:givenName H.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261756132.64
221 rdf:type schema:Person
222 sg:person.01316771114.04 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
223 schema:familyName Cavalcanti
224 schema:givenName A.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316771114.04
226 rdf:type schema:Person
227 sg:person.0647047157.16 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
228 schema:familyName Cesne
229 schema:givenName A. Le
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647047157.16
231 rdf:type schema:Person
232 sg:person.0745512151.35 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
233 schema:familyName Lassau
234 schema:givenName N.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745512151.35
236 rdf:type schema:Person
237 sg:pub.10.1007/s00261-003-0021-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021193217
238 https://doi.org/10.1007/s00261-003-0021-2
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s002800051093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049559447
241 https://doi.org/10.1007/s002800051093
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s004280000338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027401391
244 https://doi.org/10.1007/s004280000338
245 rdf:type schema:CreativeWork
246 sg:pub.10.1245/aso.2004.09.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026114831
247 https://doi.org/10.1245/aso.2004.09.011
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.amjsurg.2003.08.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047135793
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ejrad.2005.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034339089
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.ejso.2004.06.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035818796
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/s0039-6060(03)00314-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053453048
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/s0093-7754(01)90099-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024450281
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/s0140-6736(04)17098-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012604875
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/s0959-8049(02)00836-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039677991
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0959-8049(02)80608-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007366528
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1053/hupa.2002.123545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039925107
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1053/sonc.2001.29181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057078474
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1056/nejm200104053441404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026751453
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1056/nejmoa020461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022255922
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1093/annonc/mdi127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013401985
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1097/00000658-200001000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002575802
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1097/01.cad.0000132236.38297.a7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005289424
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1159/000074470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033746965
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1634/theoncologist.11-1-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045697619
284 rdf:type schema:CreativeWork
285 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
286 schema:name Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France
287 Medical Oncology, Institut Gustave Roussy, Villejuif, France
288 Pathology, Institut Gustave Roussy, Villejuif, France
289 Radiology, Institut Gustave Roussy, Villejuif, France
290 Radiotherapy, Institut Gustave Roussy, Villejuif, France
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...